Cargando…
A prospective, randomized, open-label, placebo-controlled comparative study of Bacillus coagulans GBI-30,6086 with digestive enzymes in improving indigestion in geriatric population
INTRODUCTION: Digestive symptoms are common affecting more than 60% of the elderly people. Digestive enzyme deficiency and dysbiosis in the gastric fluid microbiota are the major contributors in the pathophysiology of indigestion. Therefore, therapeutic strategy targeting the gastric microbiota and...
Autores principales: | Kumar, V. Vasanth, Sudha, Kulur Mukhyaprana, Bennur, Shilpa, Dhanasekar, Karukkupalayam Ramasamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113997/ https://www.ncbi.nlm.nih.gov/pubmed/32318476 http://dx.doi.org/10.4103/jfmpc.jfmpc_922_19 |
Ejemplares similares
-
Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization
por: Jäger, Ralf, et al.
Publicado: (2017) -
Bacillus coagulans GBI-30, 6086 improves amino acid absorption from milk protein
por: Stecker, Richard A., et al.
Publicado: (2020) -
Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery
por: Jäger, Ralf, et al.
Publicado: (2016) -
Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice
por: Fitzpatrick, Leo R, et al.
Publicado: (2012) -
Draft Genome Sequence of Bacillus coagulans GBI-30, 6086, a Widely Used Spore-Forming Probiotic Strain
por: Orrù, Luigi, et al.
Publicado: (2014)